Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Chaihu Guizhi Ganjiang Decoction is a traditional Chinese medicine (TCM) herbal formulation used for the treatment of dysmenorrhea, specifically targeting the 'cold-heat mixed pattern' (寒热错杂证). It is a modified version of the classical Chaihu Guizhi Ganjiang Decoction, a multi-herb botanical product typically containing *Bupleurum chinense*, *Cinnamomum cassia*, and *Zingiber officinale*, among other herbs. The modification is designed to optimize the formula for relieving menstrual pain and regulating the 'cold-heat' imbalance associated with uterine dysfunction. It is administered orally as a decoction. Clinical research, including a prospective randomized controlled trial conducted by the Xiangshan Hospital of Traditional Chinese Medicine Medical & Health Group, has compared its efficacy and safety against ibuprofen sustained-release capsules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Chaihu Guizhi Ganjiang Decoction.